Technical Analysis for PROG - Progenity, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Up |
| Historical PROG trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Hot IPO Pullback | Bullish Swing Setup | 0.00% | |
| Multiple of Ten Bearish | Other | 3.03% | |
| Multiple of Ten Bullish | Other | -5.17% | |
| Hot IPO Pullback | Bullish Swing Setup | 1.17% | |
| Outside Day | Range Expansion | 1.17% | |
| NR7 | Range Contraction | 9.16% | |
| Inside Day | Range Contraction | 9.16% | |
| Hot IPO Pullback | Bullish Swing Setup | 8.30% | |
| Inside Day | Range Contraction | 8.30% | |
| New 52 Week Closing Low | Bearish | 19.42% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
- Sector: Healthcare
- Industry: Biotechnology
Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.
Biotechnology Healthcare Biology Disease Genomics Drug Delivery Precision Medicine Proteomics Systems Biology Omics Systems Science
Biotechnology Healthcare Biology Disease Genomics Drug Delivery Precision Medicine Proteomics Systems Biology Omics Systems Science
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 15.92 |
| 52 Week Low | 7.63 |
| Average Volume | 327,908 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 0.00 |
| 10-Day Moving Average | 9.25 |
| Average True Range | 1.31 |
| ADX | 0.0 |
| +DI | 7.26 |
| -DI | 29.46 |
| Chandelier Exit (Long, 3 ATRs ) | 12.00 |
| Chandelier Exit (Short, 3 ATRs ) | 11.55 |
| Upper Bollinger Band | 0.00 |
| Lower Bollinger Band | 0.00 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.00 |
| MACD Line | -0.15 |
| MACD Signal Line | -0.06 |
| MACD Histogram | -0.0893 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 10.71 | ||||
| Resistance 3 (R3) | 10.62 | 10.12 | 10.52 | ||
| Resistance 2 (R2) | 10.12 | 9.82 | 10.17 | 10.45 | |
| Resistance 1 (R1) | 9.83 | 9.64 | 9.97 | 9.92 | 10.39 |
| Pivot Point | 9.33 | 9.33 | 9.41 | 9.38 | 9.33 |
| Support 1 (S1) | 9.04 | 9.03 | 9.19 | 9.14 | 8.67 |
| Support 2 (S2) | 8.54 | 8.85 | 8.59 | 8.61 | |
| Support 3 (S3) | 8.25 | 8.54 | 8.54 | ||
| Support 4 (S4) | 8.35 |
